QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

OCS

QT40Oculis Holding AG
NASDAQ·Healthcare·Biotechnology·Switzerland
Latest market price
11.22
-0.08-0.71%
OverviewShort InterestFilings
OCSQT40Oculis Holding AG·NASDAQ
OverviewShort InterestFilings
11.22-0.71%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand-
Perf Week2.00%
Market Cap646.47MForward P/E-EPS next Y-2.15Insider Trans-Shs Float-Perf Month-59.87%
Enterprise Value569.20MPEG-EPS next Q-0.60Inst Own-Short Float-Perf Quarter-55.77%
Income-114749014.00P/S1031.34EPS this Y-Inst Trans-Short Ratio-Perf Half Y-43.45%
Sales626.83KP/B2.73EPS next Y2.87%ROA-39.08%Short Interest-Perf YTD-43.82%
Book/sh-P/C-EPS next 5Y-ROE-57.09%52W High34.48 -67.46%Perf Year-43.13%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-42.07%52W Low10.52 6.65%Perf 3Y-
Dividend Est.-EV/EBITDA-4.86Sales past 3/5Y-Gross Margin-2889.37%Volatility4.44% 10.78%Perf 5Y-
Dividend TTM-EV/Sales908.07EPS Y/Y TTM11.61%Oper. Margin-16740.95%ATR (14)1.56Perf 10Y-
Dividend Ex-Date-Quick Ratio5.18Sales Y/Y TTM-Profit Margin-18861.29%RSI (14)23.68Recom2.00
Dividend Gr. 3/5Y-Current Ratio5.18EPS Q/Q18.18%SMA20-33.15%Beta0.89Target Price38.00
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA50-52.77%Rel Volume0.97Prev Close11.30
Employees49LT Debt/Eq0.01EarningsAug 06SMA200-50.83%Avg Volume771.82KPrice11.22
IPO DateMay 18, 2021Option/ShortYes / YesEPS/Sales Surpr.-28.57% -Net Debt/EBITDA0.66Volume752,232Change-0.71%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-01-26ReiteratedRobert W. Baird$49 → $38
Jun-01-26ReiteratedH.C. Wainwright$47 → $26
Jun-01-26ReiteratedNeedhamBuy$38
Jun-01-26ReiteratedGuggenheimBuy$75 → $45
May-20-26InitiatedGuggenheimBuy$75
May-12-26ReiteratedH.C. Wainwright$44 → $47
Mar-04-26ReiteratedStifel Nicolaus$40 → $50
Dec-19-25ReiteratedStifel Nicolaus$40
Oct-08-25ReiteratedChardan CapitalBuy$51
Oct-07-25ReiteratedH.C. Wainwright$33 → $36
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
Total Revenue010
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A0590
Gross Profit0-580
Selling, General and Administrative Excl. Other302516
Research and Development665933
Other Operating Expense-1-5941
Operating Income-95-83-90
Interest Expense112
Unusual Expense
———
Non-Operating Income (Expense)18147
Net Income Before Taxes-114-98-99
Income Taxes
000
Consolidated Net Income-114-98-99
Net Income From Continuing Operations-114-98-99
Net Income-114-98-99
EPS (Recurring)-2.18-2.41-3.31
EPS (Basic, Before Extraordinaries)-2.18-2.41-3.31
EPS (Diluted)-2.18-2.41-3.31
EBITDA-112-97-97
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin—-5,800.00—
Operating Margin—-8,300.00—
Net Margin—-9,800.00—
Shares Outstanding524030
Market Capitalization1,038——
Operating Lease Expense
———
Insider Trading Volume
$11.99$11.02$10.04$9.07$8.10● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR